Last Updated on December 31, 2023 by The Health Master
Download the notification: The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of two (2) formulations under the Drugs (Prices Control) Order, 2013, based on the decision of the Authority meeting held on based on the decision of 94th Authority Meeting dated 23.12.2021 vide notification S.O. 5425(E) dated 28-12-2021.
NPPA, in its order on December, 28, listed the two (2) formulations for which it has fixed retail prices. A list of the formulations has been given below:
Formulations:
| Sl. No. | Name of the Scheduled Formulation | Dosage form & Strength | Unit | Ceiling Price (Rs.) |
| (1) | (2) | (3) | (4) | (5) |
| 1. | Water for Injection | Injection | Per 500 ml Pack | 46.21 |
| 2. | Water for Injection | Injection | Per 1000 ml Pack | 81.11 |
All manufacturers of scheduled formulation, selling the branded or generic or both the versions of scheduled formulations at a price higher than the ceiling price (plus Goods and Services Tax as applicable) so fixed and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any.
All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any, shall continue to maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO, 2013.
The manufacturers may add goods and services tax only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above said table.
Note:
The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013.
The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and / or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of discontinuation.
The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955.
Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.
Latest notifications – DPCO /NPPA
FAQs – On DPCO: Drugs (Prices Control) Order, 2013
NPPA fixes retail price of 28 formulations: December 2021
NPPA fixes retail price of 20 formulations: December 2021
NPPA fixes retail price of 2 formulations: November 2021
NPPA fixes retail price of 47 formulations: November 2021
NPPA fixes retail price of 12 Anti Diabetic medicines: October 2021
NPPA fixes retail price of 23 formulations: September 2021
NPPA fixes retail price of 28 formulations: December 2021
NPPA extends price cap on liquid Medical Oxygen and Oxygen inhalation
CDSCO approves Corbevax, Covovax and Molnupiravir for restricted use
Nutraceutical sector concerned over FSSAI’s notification on Marketers
We must learn to live with Covid: WHO
Govt extends implementation date of UDI for Medical Devices
DCGI gives nod to Sun Pharma arm for Molnupiravir in India
USFDA gives nod to Granules India for Prazosin HCL capsules
E-pharmacies, Telemedicine to help cut health expenses
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
